"Parkinsonian Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Descriptor ID |
D020734
|
| MeSH Number(s) |
C10.228.140.079.862 C10.228.662.600
|
| Concept/Terms |
Parkinsonian Disorders- Parkinsonian Disorders
- Parkinsonian Syndrome
- Parkinsonism
- Parkinsonian Syndromes
- Parkinsonian Diseases
Autosomal Recessive Juvenile Parkinson Disease- Autosomal Recessive Juvenile Parkinson Disease
- Chromosome 6-Linked Autosomal Recessive Parkinsonism
- Chromosome 6 Linked Autosomal Recessive Parkinsonism
- Familial Parkinson Disease, Autosomal Recessive
- Juvenile Parkinson Disease, Autosomal Recessive
- Juvenile Parkinsonism, Autosomal Recessive
- Parkinsonism, Early Onset, with Diurnal Fluctuation
- Parkinsonism, Juvenile, Autosomal Recessive
- Parkinson Disease 2, Autosomal Recessive Juvenile
- Parkinsonism, Early-Onset, With Diurnal Fluctuation
- Parkinson Disease, Juvenile, Autosomal Recessive
- Parkinson Disease 2
- Parkinson Disease Autosomal Recessive, Early Onset
- Autosomal Recesssive Juvenile Parkinsonism
- Parkinson Disease, Familial, Autosomal Recessive
Parkinsonism, Experimental- Parkinsonism, Experimental
- Experimental Parkinsonisms
- Parkinsonisms, Experimental
- Parkinson Disease, Experimental
- Experimental Parkinsonism, MPTP-Induced
- Experimental Parkinsonism, MPTP Induced
- Parkinsonism, MPTP-Induced Experimental
- MPTP-Induced Experimental Parkinsonism
- MPTP Induced Experimental Parkinsonism
- Experimental Parkinson Disease
- Diseases, Experimental Parkinson
- Experimental Parkinson Diseases
- Parkinson Diseases, Experimental
- Experimental Parkinsonism
Parkinsonism, Juvenile- Parkinsonism, Juvenile
- Juvenile Parkinsonism
- Juvenile Parkinsonisms
- Parkinsonisms, Juvenile
- Parkinson Disease, Juvenile
- Juvenile Parkinson Disease
Autosomal Dominant Juvenile Parkinson Disease- Autosomal Dominant Juvenile Parkinson Disease
- Juvenile Parkinson Disease, Autosomal Dominant
- Parkinsonism, Juvenile, Autosomal Dominant
- Parkinson Disease, Autosomal Dominant. Juvenile
- Parkinson Disease, Juvenile, Autosomal Dominant
- Autosomal Dominant Juvenile Parkinsonism
- Juvenile Parkinsonism, Autosomal Dominant
|
Below are MeSH descriptors whose meaning is more general than "Parkinsonian Disorders".
Below are MeSH descriptors whose meaning is more specific than "Parkinsonian Disorders".
This graph shows the total number of publications written about "Parkinsonian Disorders" by people in this website by year, and whether "Parkinsonian Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 3 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 3 | 0 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 2 | 1 | 3 |
| 2006 | 3 | 0 | 3 |
| 2007 | 5 | 0 | 5 |
| 2008 | 2 | 1 | 3 |
| 2009 | 3 | 0 | 3 |
| 2010 | 3 | 0 | 3 |
| 2011 | 3 | 0 | 3 |
| 2012 | 4 | 1 | 5 |
| 2014 | 5 | 0 | 5 |
| 2015 | 2 | 0 | 2 |
| 2016 | 6 | 0 | 6 |
| 2017 | 4 | 0 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 7 | 1 | 8 |
| 2020 | 6 | 0 | 6 |
| 2021 | 7 | 1 | 8 |
| 2022 | 4 | 1 | 5 |
| 2023 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parkinsonian Disorders" by people in Profiles.
-
Relation of Motor Impairments to Neuropathologic Changes of Limbic-Predominant Age-Related TDP-43 Encephalopathy in Older Adults. Neurology. 2023 10 10; 101(15):e1542-e1553.
-
Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults. Neurology. 2023 08 15; 101(7):e754-e763.
-
Proteome-Wide Discovery of Cortical Proteins That May Provide Motor Resilience to Offset the Negative Effects of Pathologies in Older Adults. J Gerontol A Biol Sci Med Sci. 2023 03 01; 78(3):494-503.
-
Author Response: Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults. Neurology. 2022 09 27; 99(13):586.
-
Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism. Parkinsonism Relat Disord. 2022 08; 101:39-42.
-
Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neuroimage Clin. 2022; 34:103022.
-
Association of Neurofilament Light With the Development and Severity of Parkinson Disease. Neurology. 2022 05 31; 98(22):e2185-e2193.
-
Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults. Neurology. 2022 05 10; 98(19):e1976-e1984.
-
Association of White Matter Hyperintensities With Pathology and Progression of Parkinsonism in Aging. JAMA Neurol. 2021 12 01; 78(12):1494-1502.
-
Experimental colitis promotes sustained, sex-dependent, T-cell-associated neuroinflammation and parkinsonian neuropathology. Acta Neuropathol Commun. 2021 08 19; 9(1):139.